Literature DB >> 26103953

miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12.

Y Lv1, Y Lei2, Y Hu2, W Ding2, C Zhang3, C Fang3.   

Abstract

OBJECTIVES: The purpose of the study is to investigate the roles of miR-448 in ovarian cancer.
METHODS: miR-448 and CXCL12 mRNA expression were examined using qRT-PCR. CXCL12 promoter activity was detected by luciferase activity system. Cell proliferation was assayed by MTT or colony formation. Migration and invasion was assayed by transwell chamber.
RESULTS: miR-448 expression was usually under-expressed in ovarian cancer tissues and cell lines compared with their normal ones. Ectopic expression of miR-448 inhibited cell proliferation, migration and invasion in ovarian cancer cells. Moreover, bioinformatic prediction suggested that CXCL12 was a target gene of miR-448. We also demonstrated that restored expression of CXCL12 dampened miR-448-mediated suppression of tumor progression, which suggests the important role of miR-448 in tumor progression.
CONCLUSION: Our data indicate that miR-448 functions as a tumor suppressor in ovarian cancer, which exerts its activity by suppressing the expression of CXCL12.

Entities:  

Keywords:  CXCL12; Metastasis; Ovarian cancer; Proliferation; miR-448

Mesh:

Substances:

Year:  2015        PMID: 26103953     DOI: 10.1007/s12094-015-1325-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  18 in total

Review 1.  Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.

Authors:  Ayelet Dar; Orit Kollet; Tsvee Lapidot
Journal:  Exp Hematol       Date:  2006-08       Impact factor: 3.084

Review 2.  MicroRNAs in ovarian carcinomas.

Authors:  Neetu Dahiya; Patrice J Morin
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

3.  Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.

Authors:  Baoyao Xue; Weiguang Wu; Kan Huang; Tingting Xie; Xiaobo Xu; Hongju Zhang; Chunlei Qi; Junli Ge; Yuecheng Yu
Journal:  Mol Cell Biochem       Date:  2013-04-25       Impact factor: 3.396

4.  Cancer survival classification using integrated data sets and intermediate information.

Authors:  Shinuk Kim; Taesung Park; Mark Kon
Journal:  Artif Intell Med       Date:  2014-06-21       Impact factor: 5.326

Review 5.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

Review 6.  Epigenetic regulation of cancer-associated genes in ovarian cancer.

Authors:  Mi Jeong Kwon; Young Kee Shin
Journal:  Int J Mol Sci       Date:  2011-01-31       Impact factor: 5.923

Review 7.  Regulation of Metastasis by microRNAs in Ovarian Cancer.

Authors:  Yongchao Wang; Sangmi Kim; Il-Man Kim
Journal:  Front Oncol       Date:  2014-06-10       Impact factor: 6.244

Review 8.  The role of microRNAs in ovarian cancer.

Authors:  Yasuto Kinose; Kenjiro Sawada; Koji Nakamura; Tadashi Kimura
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

Review 9.  Natural history of ovarian cancer.

Authors:  Arturo Novoa Vargas
Journal:  Ecancermedicalscience       Date:  2014-09-25

Review 10.  Circulating MicroRNAs in gynecological malignancies: from detection to prediction.

Authors:  Ya-Nan Zhao; Guan-Sheng Chen; Shun-Jia Hong
Journal:  Exp Hematol Oncol       Date:  2014-05-20
View more
  18 in total

Review 1.  Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

2.  miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10.

Authors:  Xuesong Wu; Haoran Tang; Guobin Liu; Hui Wang; Jie Shu; Feng Sun
Journal:  Tumour Biol       Date:  2016-02-08

Review 3.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

4.  MiR-448 promotes vascular smooth muscle cell proliferation and migration in through directly targeting MEF2C.

Authors:  Ruihong Zhang; Li Sui; Xiaojian Hong; Mao Yang; Weimin Li
Journal:  Environ Sci Pollut Res Int       Date:  2017-08-11       Impact factor: 4.223

5.  Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer.

Authors:  Tomasz Powrózek; Paweł Krawczyk; Dariusz M Kowalski; Barbara Kuźnar-Kamińska; Kinga Winiarczyk; Marta Olszyna-Serementa; Halina Batura-Gabryel; Janusz Milanowski
Journal:  Tumour Biol       Date:  2015-09-04

6.  MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B.

Authors:  Xuehui Hong; Yang Xu; Xingfeng Qiu; Yuekun Zhu; Xing Feng; Zhijie Ding; Shifeng Zhang; Lifeng Zhong; Yifan Zhuang; Chen Su; Xinya Hong; Jianchun Cai
Journal:  Oncotarget       Date:  2016-04-19

7.  MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.

Authors:  Xiangkun Wu; Lihua Yan; Yongxi Liu; Wenfeng Xian; Liuyu Wang; Xunmeng Ding
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

Review 8.  microRNAs Make the Call in Cancer Personalized Medicine.

Authors:  Simone Detassis; Margherita Grasso; Valerio Del Vescovo; Michela A Denti
Journal:  Front Cell Dev Biol       Date:  2017-09-22

9.  Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3.

Authors:  Hao Yang; Di Wu; Hua Li; Nan Chen; Yongjun Shang
Journal:  Cell Mol Biol Lett       Date:  2018-02-22       Impact factor: 5.787

10.  miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells.

Authors:  Bai Li; Liang Ge; Minghe Li; Lei Wang; Zhihong Li
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.